Cost-effectiveness of a post-splenectomy registry for prevention of sepsis in the asplenic

Australian and New Zealand Journal of Public Health

Volumn 30, Issue 6, 2006, Pages 558-561

  Woolley, Ian ^a,b,c   Jones, Penelope ^a   Spelman, Denis ^a,c   Gold, Lisa ^d  

^a ALFRED HOSPITAL   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; INFLUENZA VACCINE; MENINGOCOCCUS VACCINE; PENICILLIN V; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC THERAPY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; HEALTH CARE DELIVERY; HUMAN; INFLUENZA; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; MORTALITY; OUTCOMES RESEARCH; PATIENT EDUCATION; POSTOPERATIVE INFECTION; PROBABILITY; REGISTER; SEPSIS; SPLENECTOMY; STREPTOCOCCUS INFECTION; VACCINATION;

ANTIBIOTIC PROPHYLAXIS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MARKOV CHAINS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REGISTRIES; RISK FACTORS; SEPSIS; SPLENECTOMY;

EID: 33846134328     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-842X.2006.tb00786.x     Document Type: Article

References (26)

1. Brigden ML, Patullo AL. Prevention and management of overwhelming postsplenectomy infection - an update. Crit Care Med. 1999;27:836-42.
2. Davidson RN, Wall RA. Prevention and management of infections in patients without a spleen. Clin Microbiol Infect. 2001;7:657-60.
3. Davies JM, Barnes R, Milligan D. British Committee for Standards in Haematology. Working Party of the Haematology/Oncology Task Force. Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Clin Med. 2002;2:440-3.
4. CDC. Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence. MMWR Morb Mortal Wkly Rep. 1993;42(RR-4):1-18.
5. Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force. Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Br Med J. 1996;312:430-4.
6. Spelman DW. Postsplenectomy overwhelming sepsis: reducing the risks. Med J Aust. 1996;164:648.
7. Spelman D. Prevention of overwhelming sepsis in asplenic patients: could do better. Lancet. 2001;357:2072.
8. Waghorn DJ. Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed. J Clin Pathol. 2001;54:2214-18.
9. MacInnes J, Waghorn DJ, Haworth E. Management of asplenic patients in South Buckinghamshire: an audit of local practice. Commun Dis Rep CDR Rev. 1995;5:R173-7.
10. Spickett GP, Bullimore J, Wallis J, Smith S, Saunders P. Northern Region asplenia register - analysis of the first two years. J Clin Pathol. 1999;52: 424-9.
11. Hegarty PK, Tan B, O'Sullivan R, Cronin CC, Brady MP. Prevention of postsplenectomy sepsis: how much do patients know? Haematol J. 2000;1: 357-59.
12. Australian Bureau of Statistics. Life Tables Victoria 2001-2003. Canberra (AUST): ABS; 2004. ABS Catalogue No.: 3302.2.55.001.
13. El-Alfy MS, El-Sayed MH. Overwhelming postsplenectomy infection: is quality of patient knowledge enough for prevention? Hematol J. 2004;5:77-80.
14. Bisharat N, Omari H, Lavi I, Raz R. Risk of infection and death among post-splenectomy patients. J Infect. 2001;43:182-6.
15. Gaston MH, Verter JI, Woods G, Pegelow C, Kelleher J, Presbury G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med. 1986;314:1593-9.
16. Jugenburg M, Haddock G, Freedman MH, Ford-Jones L, Ein SH. The morbidity and mortality of pediatric splenectomy: does prophylaxis make a difference? J Pediatr Surg. 1999;34:1064-7.
17. Konradsen HB, Henrichsen J. Pneumococcal infections in splenectomized children are preventable. Acta Paediatr Scand. 1991;80:423-7.
18. Ammann AJ, Addiego J, Wars DW, Lubin B, Smith WB, Mentzer WC. Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy. N Engl J Med. 1977;297:897-900
19. Drummond M, Sculpher M, Torrance G, O'Brien B, Stoddart G. Methods for the Economic Evaluation of Health Care Programs. 3rd ed. Oxford (UK): Oxford University Press; 2005.
20. Stone CA, Carter RC, Vos T, John JS. Colorectal cancer screening in Australia: an economic evaluation of a potential biennial screening program using faecal occult blood tests. Aust N Z J Public Health. 2004;28:273-82.
21. Magnus A, Carr V, Mihalopoulos C, Carter R, Vos T. Assessing cost-effectiveness of drug interventions for schizophrenia. Aust N Z J Psychiatry. 2005;39:44-54.
22. Green JB, Shackford SR, Sise MJ, Fridlund P. Late septic complications in adults following splenectomy for trauma: a prospective analysis in 144 patients. J Trauma. 1986;26:999-1004.
23. Shepard CW, Daneshvar MI, Kaiser RM, Ashford DA, Lonsway D, Patel JB, et al. Bordetella holmesii bacteremia: a newly recognized clinical entity among asplenic patients. Clin Infect Dis. 2004;38:799-804.
24. Khawari AA, Myers JW, Ferguson DA Jr, Moorman JP. Sepsis and meningitis due to Capnocytophaga cynodegmi after splenectomy. Clin Inffect Dis. 2005;40:1709-10.
25. Selby JV. Linking automated databases for research in managed care settings. Ann Intern Med. 1997;127:719-24.
26. Fontanesi JM, Flesher DS Jr, De Guire M, Lieberthal A, Holcomb K. The cost of doing business: cost structure of electronic immunization registries. Health Serv Res. 2002;37:1291-307.